Ventricular Tachycardia Global Clinical Trials Review, H1, 2015

Ventricular Tachycardia Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2660CTIDB
  • |
  • Pages: 81
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ventricular Tachycardia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Ventricular Tachycardia Global Clinical Trials Review, H1, 2015" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Tachycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

Ventricular Tachycardia 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials and Average Enrollment by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials 20

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Unaccomplished Trials of Ventricular Tachycardia 27

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Ventricular Tachycardia Therapeutics Clinical Trials 32

Prominent Drugs 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

Gilead Sciences, Inc. 35

Clinical Trial Overview of Gilead Sciences, Inc. 35

Baxter International Inc. 36

Clinical Trial Overview of Baxter International Inc. 36

Milestone Pharmaceuticals, Inc. 37

Clinical Trial Overview of Milestone Pharmaceuticals, Inc. 37

Jiangsu Furui Pharmaceuticals Co., Ltd 38

Clinical Trial Overview of Jiangsu Furui Pharmaceuticals Co., Ltd 38

Gilead Sciences 39

Clinical Trial Overview of Gilead Sciences 39

AstraZeneca PLC 40

Clinical Trial Overview of AstraZeneca PLC 40

Aop Orphan Pharmaceuticals AG 41

Clinical Trial Overview of Aop Orphan Pharmaceuticals AG 41

Actavis plc 42

Clinical Trial Overview of Actavis plc 42

Clinical Trial Overview of Top Institutes / Government 43

Institut de Recherches Internationales Servier 43

Clinical Trial Overview of Institut de Recherches Internationales Servier 43

Meshalkin Research Institute of Pathology of Circulation 44

Clinical Trial Overview of Meshalkin Research Institute of Pathology of Circulation 44

Aalborg University Hospital 45

Clinical Trial Overview of Aalborg University Hospital 45

Assistance Publique-Hopitaux de Paris 46

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 46

Beaumont Health System 47

Clinical Trial Overview of Beaumont Health System 47

Capital District Health Authority, Canada 48

Clinical Trial Overview of Capital District Health Authority, Canada 48

Central Finland Hospital District 49

Clinical Trial Overview of Central Finland Hospital District 49

Department of Health, UK 50

Clinical Trial Overview of Department of Health, UK 50

Duke University 51

Clinical Trial Overview of Duke University 51

El Hospital General Universitario Gregorio Maranon 52

Clinical Trial Overview of El Hospital General Universitario Gregorio Maranon 52

Five Key Clinical Profiles 53

Appendix 78

Abbreviations 78

Definitions 78

Research Methodology 79

Secondary Research 79

About GlobalData 80

Contact Us 80

Disclaimer 80

Source 81

List of Figures

Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Region (%), 2015* 9

Ventricular Tachycardia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 10

Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 11

Ventricular Tachycardia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 12

Ventricular Tachycardia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 13

Ventricular Tachycardia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 14

Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 17

Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 18

Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 19

Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 20

Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21

Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22

Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 23

Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 24

Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25

Ventricular Tachycardia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Ventricular Tachycardia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 79

List of Tables

Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Region, 2015* 9

Ventricular Tachycardia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 10

Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 11

Ventricular Tachycardia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 12

Ventricular Tachycardia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 13

Ventricular Tachycardia Therapeutics Clinical Trials, North America, Top Countries, 2015* 14

Ventricular Tachycardia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 15

Ventricular Tachycardia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 16

Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 17

Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 18

Ventricular Tachycardia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 19

Proportion of Ventricular Tachycardia to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 20

Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21

Ventricular Tachycardia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22

Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Phase, 2015* 23

Ventricular Tachycardia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24

Ventricular Tachycardia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25

Ventricular Tachycardia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 26

Ventricular Tachycardia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27

Ventricular Tachycardia Therapeutics, Global, Terminated Clinical Trials, 2015* 28

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Ventricular Tachycardia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Ventricular Tachycardia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 35

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 36

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Milestone Pharmaceuticals, Inc., 2015* 37

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jiangsu Furui Pharmaceuticals Co., Ltd, 2015* 38

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, 2015* 39

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 40

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aop Orphan Pharmaceuticals AG, 2015* 41

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 42

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2015* 43

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Meshalkin Research Institute of Pathology of Circulation, 2015* 44

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aalborg University Hospital, 2015* 45

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 46

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Beaumont Health System, 2015* 47

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 48

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Finland Hospital District, 2015* 49

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 50

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 51

Ventricular Tachycardia Therapeutics Clinical Trials Market, Global, Clinical Trials by El Hospital General Universitario Gregorio Maranon, 2015* 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Ventricular Tachycardia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Ventricular Tachycardia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161425
Site License
USD 5000 INR 322850
Corporate User License
USD 7500 INR 484275

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com